Recent Studies on Antifungal Susceptibility Patterns of Vulvovaginal Candida Species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda

Mukasa, Kiguli James and Herbert, Itabangi and Daniel, Atwine and Sserunkuma, Kibuka Livingstone and Joel, Bazira and Frederick, Byarugaba (2020) Recent Studies on Antifungal Susceptibility Patterns of Vulvovaginal Candida Species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda. In: Recent Progress in Microbiology and Biotechnology Vol. 2. B P International, pp. 15-27. ISBN 978-93-90206-59-9

Full text not available from this repository.

Abstract

Aims: To identify the Candida species that cause vulvovaginal candidiasis and determine their
antifungal susceptibility patterns.
Study Design: This was a cross-sectional study.
Place and Duration of Study: The study was conducted at the antenatal clinic of Mbarara Regional
Referral Hospital in Mbarara Municipality, between December 2012 and February 2013.
Methods: High vaginal swabs from 456 pregnant women were subjected to microscopy and culture
on Sabouraud Dextrose Agar. Candida isolates were identified by the germ tube and Analytical profile
index (API® Candida) tests. Susceptibility to fluconazole, itraconazole and voriconazole was
determined by the Etest strips and for clotrimazole and nystatin by the disc diffusion method on
Mueller Hinton agar supplemented with 2%w/v glucose and 0.5μg/ml methylene blue dye.
Results: Of the 456 High vaginal swabs cultured, 207 grew Candida species. Species distribution
was as follows: C. albicans (78.95%), C. glabrata (14.35%), C. krusei (3.35%), C. tropicalis (1.44%),
C. famata (0.96%), C. parapsilosis (0.48%) and C. lusitaniae (0.48%).
Resistance to nystatin was only observed in 0.61% of C. albicans. Resistance to clotrimazole was
observed in 50%, 36.67% and 0.61% of C. famata, C. glabrata and C. albicans respectively. C. krusei
showed a high resistance of 71.43% to fluconazole. C. glabrata, C. krusei, C. famata and C. lusitaniae
exhibited 100% resistance to itraconazole. Resistance to voriconazole of less than 11% was exhibited
by only C. albicans and C. glabrata.
Conclusion: C. albicans was susceptible to most antifungal agents tested except itraconazole and
voriconazole. All isolates were susceptible to nystatin except less than 1% of Candida albicans. Nonalbicans
demonstrated resistance to some drugs especially itraconazole. We recommend use of
Nystatin for empirical management of vulvovaginal candidiasis among pregnant women.

Item Type: Book Section
Subjects: STM Repository > Biological Science
Depositing User: Managing Editor
Date Deposited: 09 Dec 2023 04:58
Last Modified: 09 Dec 2023 04:58
URI: http://classical.goforpromo.com/id/eprint/4585

Actions (login required)

View Item
View Item